Pfizer
Global pharmaceutical company with a broad portfolio of small molecules and biologics, including vaccines and oncology products.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Nectin-4-directed antibody-drug conjugate
enzalutamideSmall molecule androgen-receptor inhibitor
Selected active clinical trials
Phase 3 · Recruiting · Multiple Myeloma
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe DiseasePhase 3 · Recruiting · COVID-19
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)Phase 3 · Recruiting · Multiple Myeloma
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual MigrainePhase 3 · Recruiting · Menstrual Migraine
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.Phase 3 · Recruiting · Metastatic Castration-Resistant Prostate Cancer
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease VaccinePhase 3 · Recruiting · Lyme Disease
Selected patent records
apixaban · Expires 2026-11-21
US 7214695tafamidis meglumine · Expires 2026-12-19
US 7214696tafamidis meglumine · Expires 2026-12-19
US RE47739palbociclib · Expires 2027-03-05
US 6967208*PEDapixaban · Expires 2027-05-21
US RE47739*PEDpalbociclib · Expires 2027-09-05
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/pfizer/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.